Introduction
Next-generation pharmacovigilance (PV) technology is going to disrupt old school approaches and outdated processes that haven’t changed in years. This disruption may be painful, but it is necessary, and the organizations and PV experts who are willing to adapt, stand to gain substantial benefits.
As anyone who has been through a system evolution knows, new technology always has a business impact. The business inevitably embraces these technologies -- but only after shedding a lot of blood, sweat and tears.
The current PV evolution will be no different.
尽管在整个生物制药景观中都取得了进步，但几十年来，PV组织没有看到任何开创性的技术变化。一直有团队致力于将数据输入和脱离系统，创作汇总报告并验证医疗准确性和完整性以及其他任务。但是，大多数效率是通过外包和零碎的自动化而不是部署新技术来寻求的。今天，这还不够。